The two below quotes from two different sources, when combined, illustrate the real transformational potential MEM has available on the horizon.
The first quote is from an article about China's IVF market, and the second quote is from a social media post by Memphasys (both sources for the quotes a shown below).
Quote 1
"In terms of market size, China’s ART services are valued at approximately US$2.31 billion in 2023, and this is expected to grow to US$3.90 billion by 2030, marking a compound annual growth rate (CAGR) of 7.8 percent between 2024 and 2030. This significant growth can be attributed to several factors, including a rising number of infertile couples, greater societal acceptance of ART procedures, and supportive government policies aimed at reversing declining birth rates"
Quote 2
"The hospital is already using Felix.......as Memphays progresses towards formal product registration in China"
(20min delay)